4//SEC Filing
Neville Everett 4
Accession 0001225208-23-002994
CIK 0001739940other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:01 PM ET
Size
9.4 KB
Accession
0001225208-23-002994
Insider Transaction Report
Form 4
Neville Everett
See Remarks
Transactions
- Award
Common Stock, $.01 Par Value
2023-02-24+4,694→ 13,241 total - Tax Payment
Common Stock, $.01 Par Value
2023-02-24$294.27/sh−1,683$495,256→ 11,330 total - Tax Payment
Common Stock, $.01 Par Value
2023-02-24$294.27/sh−228$67,094→ 13,013 total - Sale
Common Stock, $.01 Par Value
2023-02-27$294.06/sh−1,772$521,074→ 9,558 total
Footnotes (4)
- [F1]The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
- [F2]Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
- [F3]Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
- [F4]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2022.
Documents
Issuer
Cigna Group
CIK 0001739940
Entity typeother
Related Parties
1- filerCIK 0001641142
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 6:01 PM ET
- Size
- 9.4 KB